Label: ALLERGY RELIEF-D- cetirizine hydrochloride, pseudoephedrine hydrochloride tablet, film coated, extended release
- NDC Code(s): 11822-3009-0
- Packager: Rite Aid Corporation
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated May 1, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients (in each extended release tablet)
- Purpose
-
Uses
- •
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- •
- runny nose
- •
- sneezing
- •
- itchy, watery eyes
- •
- itching of the nose or throat
- •
- nasal congestion
- •
- reduces swelling of nasal passages
- •
- temporarily relieves sinus congestion and pressure
- •
- temporarily restores freer breathing through the nose
-
Warnings
Do not use
- •
- if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
- •
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- •
- heart disease
- •
- thyroid disease
- •
- diabetes
- •
- glaucoma
- •
- high blood pressure
- •
- trouble urinating due to an enlarged prostate gland
- •
- liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
- •
- do not use more than directed
- •
- drowsiness may occur
- •
- avoid alcoholic drinks
- •
- alcohol, sedatives, and tranquilizers may increase drowsiness
- •
- be careful when driving a motor vehicle or operating machinery
Stop use and ask a doctor if
- •
- an allergic reaction to this product occurs. Seek medical help right away.
- •
- you get nervous, dizzy, or sleepless
- •
- symptoms do not improve within 7 days or are accompanied by fever
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
Package/Label Principal Display Panel
12 HOUR RELIEF
FREE FROM
GLUTEN FREE
ORIGINAL PRESCRIPTION STRENGTH
Compare to the active ingredients of Zyrtec-D®
ALLERGY RELIEF-D
CETIRIZINE HYDROCHLORIDE, 5 mg and PSEUDOEPHEDRINE HYDROCHLORIDE, 120 mg
EXTENDED-RELEASE TABLETS
ANTIHISTAMINE/NASAL DECONGESTANT
INDOOR + OUTDOOR ALLERGIES
ACTUAL SIZE
NASAL CONGESTION + SINUS PRESSURE
Sneezing ● Itchy, watery eyes ● Runny nose
Itchy nose or throat
ALLERGY + SINUS
24 EXTENDED RELEASE TABLETS
-
INGREDIENTS AND APPEARANCE
ALLERGY RELIEF-D
cetirizine hydrochloride, pseudoephedrine hydrochloride tablet, film coated, extended releaseProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:11822-3009 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE 5 mg PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg Inactive Ingredients Ingredient Name Strength SILICON DIOXIDE (UNII: ETJ7Z6XBU4) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 2165RE0K14) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990) TALC (UNII: 7SEV7J4R1U) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Product Characteristics Color WHITE Score no score Shape ROUND Size 10mm Flavor Imprint Code L147 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:11822-3009-0 24 in 1 CARTON 05/01/2023 1 1 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA210719 05/01/2023 Labeler - Rite Aid Corporation (014578892)